Ipilimumab-associated minimal-change disease

Kidney Int. 2016 Mar;89(3):720. doi: 10.1016/j.kint.2015.11.028.

Authors

Jason M Kidd¹, Andinet B Gizaw²

Affiliations

¹ Department of Internal Medicine, Division of Nephrology, Virginia Commonwealth University Medical Center, Richmond, Virginia, USA. Electronic address: jason.kidd@vcuhealth.org.
² Department of Internal Medicine, Division of Nephrology, Virginia Commonwealth University Medical Center, Richmond, Virginia, USA.

PMID: 26880464
DOI: 10.1016/j.kint.2015.11.028

No abstract available

Publication types

Letter
Comment

MeSH terms

Antineoplastic Agents / adverse effects*
Humans
Kidney Diseases / chemically induced*

Substances

Antineoplastic Agents